Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fong

Showing results (591-600 of 723) with videos related to

Pageof 73
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Oncogene|March 12, 2003
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancersAngelo Agathanggelou, Ashraf Dallol, Sabine Zöchbauer-Müller, et al.
Journal of Medicinal Chemistry|March 13, 2008
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonistLinus S Lin, Sookhee Ha, Richard G Ball, et al.
JMIR Human Factors|July 24, 2023
Using Intervention Mapping and Behavior Change Techniques to Develop a Digital Intervention for Self-Management in Stroke: Development StudyAlex W K Wong, Mandy W M Fong, Elizabeth G S Munsell, et al.
Molecular Imaging and Biology|January 9, 2009
PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119Terence G Hamill, Linus S Lin, William Hagmann, et al.
Journal of Physical Therapy Science|June 18, 2016
Comparison between smartphone pedometer applications and traditional pedometers for improving physical activity and body mass index in community-dwelling older adultsShirley S M Fong, Shamay S M Ng, Yoyo T Y Cheng, et al.
Thorax|April 24, 2025
Future risk projection to engage 'near-miss' individuals in lung cancer screening eligibility: an analysis of ILST dataChellan Kumarasamy, Kim Betts, Richard Norman, et al.
The Journal of Clinical Investigation|April 17, 2003
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humansDavid H McDermott, Alan M Fong, Qiong Yang, et al.
Journal of the International AIDS Society|June 26, 2020
"Patients are not the same, so we cannot treat them the same" - A qualitative content analysis of provider, patient and implementer perspectives on differentiated service delivery models for HIV treatment in South AfricaSophie J S Pascoe, Nancy A Scott, Rachel M Fong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2009
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillanceS T Chien, J C Hsueh, H-H Lin, et al.
Pageof 73

Showing results (591-600 of 723) with videos related to

Sort By:
Pageof 73
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Oncogene|March 12, 2003
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancersAngelo Agathanggelou, Ashraf Dallol, Sabine Zöchbauer-Müller, et al.
Journal of Medicinal Chemistry|March 13, 2008
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonistLinus S Lin, Sookhee Ha, Richard G Ball, et al.
JMIR Human Factors|July 24, 2023
Using Intervention Mapping and Behavior Change Techniques to Develop a Digital Intervention for Self-Management in Stroke: Development StudyAlex W K Wong, Mandy W M Fong, Elizabeth G S Munsell, et al.
Molecular Imaging and Biology|January 9, 2009
PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119Terence G Hamill, Linus S Lin, William Hagmann, et al.
Journal of Physical Therapy Science|June 18, 2016
Comparison between smartphone pedometer applications and traditional pedometers for improving physical activity and body mass index in community-dwelling older adultsShirley S M Fong, Shamay S M Ng, Yoyo T Y Cheng, et al.
Thorax|April 24, 2025
Future risk projection to engage 'near-miss' individuals in lung cancer screening eligibility: an analysis of ILST dataChellan Kumarasamy, Kim Betts, Richard Norman, et al.
The Journal of Clinical Investigation|April 17, 2003
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humansDavid H McDermott, Alan M Fong, Qiong Yang, et al.
Journal of the International AIDS Society|June 26, 2020
"Patients are not the same, so we cannot treat them the same" - A qualitative content analysis of provider, patient and implementer perspectives on differentiated service delivery models for HIV treatment in South AfricaSophie J S Pascoe, Nancy A Scott, Rachel M Fong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2009
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillanceS T Chien, J C Hsueh, H-H Lin, et al.
Pageof 73